<DOC>
	<DOC>NCT02173249</DOC>
	<brief_summary>The purpose of this study is to evaluate the Plasma Pharmacokinetics and Safety of AC 170 0.24% in Healthy, Adult Subjects when used twice daily for one week.</brief_summary>
	<brief_title>A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%</brief_title>
	<detailed_description />
	<mesh_term>Cetirizine</mesh_term>
	<criteria>at least 18 and no older than 55 years of age be able to selfadminister eye drops or have a parent/legal guardian available for this purpose have blood and urine analysis within normal limits have ocular health within normal limits known contraindications or sensitivities to the study medication or its components have any active systemic or ocular disorder (other than refractive disorder) have inability to comply with controlled diet have used prescription or non prescription drugs within washout period and throughout study have used alcohol or tobacco within the washout period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>